Cargando…

Progress of clinical research on targeted therapy combined with thoracic radiotherapy for non-small-cell lung cancer

The combination of radiotherapy and targeted therapy is an important approach in the application of targeted therapy in clinical practice, and represents an important opportunity for the development of radiotherapy itself. Numerous agents, including epidermal growth factor receptor, monoclonal antib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuang, Hongqing, Zhao, Xianzhi, Zhao, Lujun, Chang, Joe Y, Wang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047835/ https://www.ncbi.nlm.nih.gov/pubmed/24936128 http://dx.doi.org/10.2147/DDDT.S61977

Ejemplares similares

Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy
por: Zhuang, Hongqing, et al.
Publicado: (2014)

Does the response to induction chemotherapy impact the timing of thoracic radiotherapy for limited-stage small-cell lung cancer?
por: Wang, Peng, et al.
Publicado: (2015)

Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not?
por: Luo, Jing, et al.
Publicado: (2017)

Phase II study of whole brain radiotherapy with or without erlotinib in patients with multiple brain metastases from lung adenocarcinoma
por: Zhuang, Hongqing, et al.
Publicado: (2013)

Thoracic Radiotherapy Benefits Elderly Extensive-Stage Small Cell Lung Cancer Patients with Distant Metastasis
por: Qi, Jing, et al.
Publicado: (2019)

Nomograms for predicting progression and efficacy of post-operation radiotherapy in IIIA-pN2 non-small cell lung cancer patients
por: Zhang, Baozhong, et al.
Publicado: (2017)

Risk Prediction Model for Synchronous Oligometastatic Non-Small Cell Lung Cancer: Thoracic Radiotherapy May Not Prolong Survival in High-Risk patients
por: Meng, Chunliu, et al.
Publicado: (2022)

Influence of different image-guided tracking methods upon the local efficacy of CyberKnife treatment in lung tumors
por: Guo, Yihang, et al.
Publicado: (2015)

MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma
por: Zhuang, Hongqing, et al.
Publicado: (2016)

Effects of thoracic radiotherapy timing and duration on progression‐free survival in limited‐stage small cell lung cancer
por: Zhao, Shen, et al.
Publicado: (2018)

Effect of stereotactic radiotherapy on immune microenvironment of lung cancer
por: Xiao, Yao, et al.
Publicado: (2022)

Functional lung imaging in thoracic tumor radiotherapy: Application and progress
por: Zhou, Pi-Xiao, et al.
Publicado: (2022)

International consensus on radiotherapy in metastatic non-small cell lung cancer
por: Zhu, Zhengfei, et al.
Publicado: (2022)

Research progress on the impact of radiation on TKI resistance mechanisms in NSCLC
por: Zhuang, Hongqing
Publicado: (2018)

Simultaneous integrated dose reduction intensity-modulated radiotherapy applied to an elective nodal area of limited-stage small-cell lung cancer
por: LIU, ZHIYAN, et al.
Publicado: (2015)

Consolidative thoracic radiotherapy for extensive stage small cell lung cancer
por: Zhang, Xiaoli, et al.
Publicado: (2017)

Thoracic radiotherapy in small cell lung cancer—a narrative review
por: Levy, Antonin, et al.
Publicado: (2021)

Clinical results of intensity-modulated radiotherapy for 250 patients with cervical and upper thoracic esophageal carcinoma
por: Zhang, Jiaqi, et al.
Publicado: (2019)

Research Progress on Radiotherapy Combined with Immunotherapy for Associated Pneumonitis During Treatment of Non-Small Cell Lung Cancer
por: Zhang, Anqi, et al.
Publicado: (2022)

Could the clinical target volume be omitted for radiotherapy of locally advanced non-small cell lung cancer in the modern era?
por: Verma, Vivek, et al.
Publicado: (2021)

Abscopal effect of stereotactic radiotherapy combined with anti‐PD‐1/PD‐L1 immunotherapy: Mechanisms, clinical efficacy, and issues
por: Zhuang, Hongqing
Publicado: (2020)

Research Progress of Heavy Ion Radiotherapy for Non-Small-Cell Lung Cancer
por: Liang, Siqi, et al.
Publicado: (2022)

Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer
por: Haslett, K., et al.
Publicado: (2021)

Preliminary Results about Application of Intensity-Modulated Radiotherapy to Reduce Prophylactic Radiation Dose in Limited-Stage Small Cell Lung Cancer
por: Liu, Zhiyan, et al.
Publicado: (2018)

Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer
por: Xu, Li-Ming, et al.
Publicado: (2017)

XRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma
por: Cheng, Jingjing, et al.
Publicado: (2015)

The influence of the metastasis pattern of mediastinal lymph nodes on the postoperative radiotherapy’s efficacy for the IIIA-pN2 non-small-cell lung cancer: a retrospective analysis of 220 patients
por: Zhang, Baozhong, et al.
Publicado: (2016)

Role of thoracic radiotherapy in extensive stage small cell lung cancer: a systemic review and meta-analysis
por: Li, Ao-Mei, et al.
Publicado: (2021)

TGFβ1 in Cancer-Associated Fibroblasts Is Associated With Progression and Radiosensitivity in Small-Cell Lung Cancer
por: Zhang, Jiaqi, et al.
Publicado: (2021)

Current Management and Progress in Radiotherapy for Small Cell Lung Cancer
por: Tjong, Michael C., et al.
Publicado: (2020)

Benefit from thoracic radiotherapy in patients with extensive-disease small-cell lung cancer with elevated lactate dehydrogenase
por: Qin, Tao, et al.
Publicado: (2016)

Simultaneous integrated dose reduction intensity-modulated radiotherapy effectively reduces cardiac toxicity in limited-stage small cell lung cancer
por: Luo, Jing, et al.
Publicado: (2023)

Palliative thoracic radiotherapy dose, non-small cell lung cancer with oligometastases and prognosis
por: Ampil, Federico L., et al.
Publicado: (2011)

Feasibility study of DCs/CIKs combined with thoracic radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer
por: Zhang, Luping, et al.
Publicado: (2016)

Sequential Versus Concurrent Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for N3 Limited-Stage Small-Cell Lung Cancer
por: Wang, Zhenbo, et al.
Publicado: (2020)

Proton-Based Stereotactic Ablative Radiotherapy in Early-Stage Non-Small-Cell Lung Cancer
por: Grant, Jonathan D., et al.
Publicado: (2014)

Tracheoesophageal fistula associated with bevacizumab after thoracic radiotherapy in non-small cell lung cancer: A case report
por: Zhang, Tao, et al.
Publicado: (2020)

Fractionated palliative thoracic radiotherapy in non-small cell lung cancer – futile or worth-while?
por: Støchkel Frank, Malene, et al.
Publicado: (2018)

The role of thoracic consolidative radiotherapy in the setting of immunotherapy in extensive stage small cell lung cancer
por: Verma, Saurav, et al.
Publicado: (2023)

Tyrosine Kinase Inhibitor Resistance Increased the Risk of Cerebral Radiation Necrosis After Stereotactic Radiosurgery in Brain Metastases of Non-small-Cell Lung Cancer: A Multi-Institutional Retrospective Case-Control Study
por: Zhuang, Hongqing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_18ug2sqfieed21g155ho2thn1o